Wolverine Blend

Third-Party Tested

Independent lab verified

Batch-Specific CoA

Publicly accessible

YPB.217

Reference number

10mg+10mg

Lyophilized vial

Origin

The Wolverine Blend combines BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4) at equal dosing in a single vial. Both peptides have independent research histories spanning decades — BPC-157 from Croatian gastric juice research since the 1990s, and TB-4 from thymic peptide research since the 1960s. The combination is named for the fictional character's regenerative abilities.

Research Lineage

While BPC-157 and TB-500 each have extensive independent publication records (150+ and 1,000+ papers respectively), research into their combined effects is more limited. The rationale for co-administration is based on their complementary mechanisms — BPC-157's NO system and growth factor interactions paired with TB-4's actin-sequestering and cell migration properties. Preclinical combination studies have been investigated in tissue repair models.

Mechanism of Action

The blend pairs two mechanistically distinct repair-associated peptides. BPC-157 has been observed to modulate the nitric oxide system and upregulate growth factor receptor expression, while TB-500 regulates cytoskeletal dynamics through actin sequestration and promotes endothelial cell migration. The combination is investigated for potential synergistic effects through these complementary pathways.